Other equities analysts have also recently issued research reports about the stock. Vetr cut shares of Cardinal Health from a buy rating to a hold rating and set a $76.99 price target on the stock. in a research report on Tuesday, January 3rd. Barclays PLC set a $88.00 price objective on shares of Cardinal Health and gave the stock a buy rating in a research note on Monday, November 14th. Mizuho lowered shares of Cardinal Health from a buy rating to a neutral rating and set a $79.00 price objective on the stock. in a research note on Tuesday, January 3rd. Robert W. Baird lowered shares of Cardinal Health from an outperform rating to a neutral rating and dropped their price objective for the stock from $92.00 to $82.00 in a research note on Friday, October 28th. Finally, Zacks Investment Research upgraded shares of Cardinal Health from a sell rating to a hold rating in a research note on Monday, November 14th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of Hold and an average target price of $88.54.
Shares of Cardinal Health (NYSE:CAH) opened at 77.40 on Wednesday. The firm has a 50-day moving average price of $74.76 and a 200-day moving average price of $75.73. The stock has a market cap of $24.42 billion, a price-to-earnings ratio of 18.64 and a beta of 0.71. Cardinal Health has a one year low of $62.70 and a one year high of $87.85.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, February 7th. The company reported $1.34 EPS for the quarter, topping the consensus estimate of $1.23 by $0.11. Cardinal Health had a net margin of 1.06% and a return on equity of 25.52%. The business had revenue of $33.10 billion for the quarter, compared to analysts’ expectations of $33.63 billion. During the same quarter last year, the company posted $1.30 earnings per share. The company’s quarterly revenue was up 5.4% compared to the same quarter last year. Analysts anticipate that Cardinal Health will post $5.42 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Saturday, April 15th. Investors of record on Monday, April 3rd will be issued a dividend of $0.4489 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date of this dividend is Thursday, March 30th. Cardinal Health’s payout ratio is 43.17%.
A number of hedge funds have recently modified their holdings of CAH. UBS Asset Management Americas Inc. increased its position in shares of Cardinal Health by 20.2% in the third quarter. UBS Asset Management Americas Inc. now owns 1,370,584 shares of the company’s stock worth $106,495,000 after buying an additional 230,169 shares in the last quarter. Ngam Advisors L.P. increased its position in shares of Cardinal Health by 3.9% in the second quarter. Ngam Advisors L.P. now owns 87,936 shares of the company’s stock worth $6,860,000 after buying an additional 3,301 shares in the last quarter. IFC Holdings Incorporated FL increased its position in shares of Cardinal Health by 17.9% in the second quarter. IFC Holdings Incorporated FL now owns 3,188 shares of the company’s stock worth $249,000 after buying an additional 483 shares in the last quarter. Foster & Motley Inc. acquired a new position in shares of Cardinal Health during the second quarter worth about $505,000. Finally, Shelton Capital Management increased its position in shares of Cardinal Health by 78.6% in the second quarter. Shelton Capital Management now owns 10,914 shares of the company’s stock worth $851,000 after buying an additional 4,803 shares in the last quarter. Hedge funds and other institutional investors own 85.84% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/leerink-swann-analysts-give-cardinal-health-inc-cah-a-81-00-price-target/1657327.html
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.